| TGA Action ID |
RC-2026-RN-00925-1 |
| Type of Product |
Medical Device |
| Product Name/Description |
Streptex Latex Agglutination Test. An in vitro diagnostic medical device (IVD).
Lot Number: 6416336
Expiry Date: 15/07/2027
Product Reference Code: R30950501 |
| ARTG Number |
236824 |
| Action Type |
Recall |
| Action Level |
Hospital |
| Hazard Classification |
Class III |
| Reason for the Action |
A cross reaction has been identified that may cause false negative reactions. Extraction Enzyme Lot 6339390 (contained within the product R30950501 Lots 6416336) may provide atypical performance when used with Streptex D Latex reagent Lot 6408670. The Group D reagent in the lot 6416336 may exhibit some deterioration over time.
There should be no immediate or long-term health consequences from use of this lot. Users should include positive and negative controls in any event as standard quality controls.
Streptex is a confirmatory test, gram smear, bile esculin. haemolysis on blood agar, etc., are required for identification of enterococci from appropriate clinical specimens. Patient outcomes are unlikely to be affected by a failure to identify this serogroup. The clinical risk should be considered low.
To date, no adverse events have been reported in relation to this problem. |
| Instructions for Customers/Users |
Customers are to: - Immediately quarantine the product in your inventory to prevent any further use. - Destroy the product in their inventory or return it to Thermo Fisher Scientific.
If customers have consumed the product, they should review the customer letter with their Medical Director to determine the appropriate course of action, including reviewing previously generated results for any anomalies in line with local procedures. |
| Action Commencement Date |
16/11/2026 |
| Responsible Entity |
|
| Contact Information |
1300 736 767 - Thermo Fisher Scientific |